PBM logo

Psyence Biomedical (PBM) Company Overview

Profile

Full Name:

Psyence Biomedical Ltd.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Canada

IPO:

December 10, 2021

Indexes:

Not included

Description:

Psyence Biomedical is a company focused on developing and commercializing psychedelic products for mental health and wellness, aiming to improve treatment options for various psychological conditions.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 26, 2024

Analyst ratings

Recent major analysts updates

No data about analysts updates

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

CVS's Sell-Off May Be Overblown
CVS's Sell-Off May Be Overblown
CVS's Sell-Off May Be Overblown
PBM
seekingalpha.comDecember 15, 2024

CVS plunged to $49, trading at a forward P/E of 8-9x, well below its 16x historical average. PBM segment contributes 46% of CVS income; fears of reform impact led to significant market overreaction. A 25% PBM profitability cut reduces EPS to ~$4, implying a fair value of $60 (with a P/E of 15x).

CVS Health Hits 11-Year Low; PBM Legislation Could Slash Earnings By 50%, Says Analyst
CVS Health Hits 11-Year Low; PBM Legislation Could Slash Earnings By 50%, Says Analyst
CVS Health Hits 11-Year Low; PBM Legislation Could Slash Earnings By 50%, Says Analyst
PBM
investors.comDecember 12, 2024

New legislation targeting pharmacy benefit managers (PBMs) could cut CVS Health earnings in half. CVS stock fell, along with UnitedHealth and Cigna.

FAQ

  • What is the ticker symbol for Psyence Biomedical?
  • Does Psyence Biomedical pay dividends?
  • What sector is Psyence Biomedical in?
  • What industry is Psyence Biomedical in?
  • What country is Psyence Biomedical based in?
  • When did Psyence Biomedical go public?
  • Is Psyence Biomedical in the S&P 500?
  • Is Psyence Biomedical in the NASDAQ 100?
  • Is Psyence Biomedical in the Dow Jones?
  • When does Psyence Biomedical report earnings?

What is the ticker symbol for Psyence Biomedical?

The ticker symbol for Psyence Biomedical is NASDAQ:PBM

Does Psyence Biomedical pay dividends?

No, Psyence Biomedical does not pay dividends

What sector is Psyence Biomedical in?

Psyence Biomedical is in the Healthcare sector

What industry is Psyence Biomedical in?

Psyence Biomedical is in the Biotechnology industry

What country is Psyence Biomedical based in?

Psyence Biomedical is headquartered in Canada

When did Psyence Biomedical go public?

Psyence Biomedical's initial public offering (IPO) was on December 10, 2021

Is Psyence Biomedical in the S&P 500?

No, Psyence Biomedical is not included in the S&P 500 index

Is Psyence Biomedical in the NASDAQ 100?

No, Psyence Biomedical is not included in the NASDAQ 100 index

Is Psyence Biomedical in the Dow Jones?

No, Psyence Biomedical is not included in the Dow Jones index

When does Psyence Biomedical report earnings?

The date for Psyence Biomedical's next earnings report has not been announced yet